NCT03033355View on ClinicalTrials.gov

Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Multiple SclerosisLower Urinary Tract SymptomsNeurogenic BladderDetrusor, OveractiveUrge Incontinence
Interventions
DRUG

Intra-detrusor injection of Onabotulinumtoxin-A

Using cystoscopy, Onabotulinumtoxin-A is injected into the bladder.

Trial Locations (1)

77030

Houston Methodist Hospital, Houston

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER

NCT03033355 - Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder | Biotech Hunter | Biotech Hunter